Evaluating satisfaction of patients with stutter regarding the tele-speech therapy method and infrastructure

Jahromi, Maryam Eslami; Ahmadian, Leila

doi:10.1016/j.ijmedinf.2018.03.004

Cited by 49 publications

(36 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The most frequently emphasized barriers to telepractice were internet connections ( n = 8), computers ( n = 4) and routine or non-routine audio problems ( n = 4), as reported in literature previously ( Jahromi & Ahmadian, 2018 ; Tucker, 2012b ).…”

Section: Discussionsupporting

confidence: 52%

“…However, five other participants reported that they would choose in-person therapy if they could access those services, which was consistent with the literature ( Carey et al, 2014 ; Langevin, Lomheim, & Williston, 2015 ). The positive perspectives of the participants on the advantages of telepractice are emphasized frequently in the literature (e.g., Jahromi & Ahmadian, 2018 ; McGill et al, 2019 ).…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Stuttering therapy through telepractice in Turkey: A mixed method study

Cangi

Toğram

2020

Journal of Fluency Disorders

View full text Add to dashboard Cite

Highlights Considering the quantitative findings, the telepractice and in-person groups showed a performance on an equivalent level. The greatest majority of the participants reported that they had adapted to telepractice and that this method was appropriate for them, despite barriers. For the clinician, loss of time, cost, and effort occurred more than expected for telepractice service. Some qualifications, such as experience, psychological factors, and lifestyle, have emerged as suitable candidate criteria for telepractice and the success of treatment. This delivery method can be a great alternative when in-person services cannot be carried out in circumstances such as rural life or global disasters like COVID-19 Pandemic.

show abstract

Section: Discussionsupporting

confidence: 52%

Section: Discussionmentioning

confidence: 99%

Stuttering therapy through telepractice in Turkey: A mixed method study

Cangi

Toğram

2020

Journal of Fluency Disorders

View full text Add to dashboard Cite

show abstract

“…Although no specific figures were given, the report indicated that the service improved access to care, reduced emergency department visits/hospitalizations, and resulted in cost savings, including reduced travel expenses, medical expenses, and support costs. Similar cost savings were reported in other studies [54,59].…”

Section: Service Delivery Efficiencies and Economic Impactsupporting

confidence: 89%

“…We found 2 papers that discussed clinical insights from health care professionals who were involved in telehealth treatment delivery for patients with stuttering [57,58]. We also found a descriptive-analytic study of satisfaction with telehealth treatment for stuttering [59]. Furthermore, we found 2 papers on a pilot open-case series (QR=4) [60] and an RCT that used a waiting list control for the assessment and treatment of chronic tic disorders (QR=2) [61].…”

Section: Summary Of Other Treatment Papersmentioning

confidence: 99%

“…The use of telehealth to train health care professionals was shown to be a promising way of providing support to practitioners in the field [58]. Jahromi and Ahmadian [59] explored satisfaction in telespeech therapy among 30 Iranian patients aged ≥14 years. The authors reported that satisfaction with the therapy was high, but the low internet speed in the country was a major challenge for half the participants, as they could not maintain eye contact with the therapist due to the distorted image transmission.…”

Section: User Impact Feasibility and Acceptabilitymentioning

confidence: 99%

See 1 more Smart Citation

Implementation of Telehealth Services to Assess, Monitor, and Treat Neurodevelopmental Disorders: Systematic Review (Preprint)

Valentine¹,

Hall²,

Young³

et al. 2020

Preprint

View full text Add to dashboard Cite

BACKGROUND Telehealth has rapidly developed over the past 20 years, so it is essential we identify effective telehealth technologies for implementation in clinical practice. In response to COVID-19 there is increasing momentum behind the development and delivery of telehealth. Therefore, to assess the anticipated exponential growth in telehealth it is important we accurately capture how telehealth was used in specific fields of mental health prior to COVID-19. OBJECTIVE The aim of this review was to highlight how, prior to COVID-19, telehealth had been used (i.e. assessment, treatment, monitoring) with clinical samples in the neurodevelopmental (NDD) field, including for patients with NDD, their families, and healthcare professionals (HCPs). In order to identify which technologies may show greatest clinical and cost-effectiveness for implementation into health services post COVID-19 the review evaluates the technologies for effectiveness, cost efficiencies, and readiness for clinical adoption. The quality of the evidence and gaps in the literature are also considered to guide future work. METHODS A systematic search of the literature was undertaken (April 2018 - updated until December 2019) using the following databases: Medline, Web of Science, Scopus, CINAHL Plus, Embase, and PsycInfo. Data extracted included the type of technology, how the technology was used (assessment, treatment, monitoring), participant characteristics, reported outcomes and the authors’ views on clinical effectiveness, user impact, feasibility and acceptability, service delivery efficiencies and economic impact, and readiness for clinic adoption. A quality review of the research is also reported. RESULTS A total of 42 studies met the inclusion criteria. These included participants and/or their families with autism spectrum disorders (ASD; n=22), attention deficit hyperactivity disorders (ADHD; n=8), ADHD and/or ASD (n=3), communication disorders (n=7), and tic disorders (n=2). The majority of studies were with children/young people and/or their caregivers. The focus of most studies was treatment (n=33), rather than assessment (n=4) or monitoring (n=5). In terms of clinical effectiveness, telehealth services were usually equivalent to controls (e.g. face-to-face services or services without therapist input), costs were generally not reported but when they were telehealth was seen as being cost-effective. The quality of the studies varied, with many having small sample sizes and inadequate control groups. CONCLUSIONS The use of telehealth has the potential to increase the availability of treatment, decrease waiting times for diagnosis, and aid in the monitoring of NDD, post COVID-19. Further research, with more robust and adequately powered study designs as well as consideration of cost-effectiveness and efficiency savings, is needed. The review highlights the extent of the use of telehealth technologies prior to COVID-19 and the movement to invest in remote access to treatments.

show abstract